Clinical trial
Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced…
NCT00077948 · Gilead Sciences, Industry · Terminated
Key facts
| NCT number | NCT00077948 |
|---|---|
| Title | Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure |
| Official title | A Phase III, Randomized, Double-Blind, Double Placebo-Controlled, Multicenter, Three Parallel Group Study of Enoximone Plus Extended-Release Metoprolol Succinate in Advanced CHF Subjects Previously Intolerant to Beta-Blocker Treatment |
| Lead sponsor | Gilead Sciences, Industry |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Enoximone, Metoprolol succinate, Placebo to match enoximone, Placebo to match metoprolol succinate |
| Enrollment | 175 |
| Start date | Jul 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Feb 18, 2004 |
| Last update posted | Jan 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: